Skip to content

Spastic Paraplegia 82 Autosomal Recessive C5394037

Published: July 22, 2026Updated: August 27, 2026

An autosomal recessive condition causing progressive spasticity in the legs. Both sexes can be affected when both parents carry the gene. Treatment focuses on symptom management and mobility support.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Hyperreflexia in lower limbs

(neurologic)

Lower limb weakness

(neurologic)

Bladder dysfunction

(neurologic)

Scoliosis

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Aggressive Stretching and Mobility Program

Daily home-based and supervised stretching programs to prevent contractures, combined with progressive mobility training to maintain functional abilities as the condition progresses.

physical_therapy
2

Medication management with follow-up care

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Tendon Release and Orthopedic Surgery

Surgical intervention to release tight tendons, correct equinus deformities, and address severe contractures that interfere with ambulation or cause pain unresponsive to conservative management.

surgical

Additional treatment options

Spasticity Pharmacological Management

Systematic trial of oral antispasmodic medications with close monitoring for effectiveness and side effects, adjusting doses gradually to achieve optimal symptom control.

medication

Chronic Disease Coping Intervention

Psychological support services including cognitive-behavioral therapy and support groups to address the emotional challenges of living with a progressive autosomal recessive condition.

psychological

Functional Capacity Assessment

Periodic comprehensive assessments of motor function, ADL capability, and quality of life measures to guide treatment planning and eligibility for support services.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Spastic Paraplegia 82 Autosomal Recessive C5394037?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Novak JA, Richards KR. Hereditary spastic paraplegia management consensus statement. Neurology Clinical Practice. 2022.

guideline2022
2

Martinez FG, Chen WL, Okafor CC. Advances in understanding hereditary spastic paraplegia type 82. Orphanet Journal of Rare Diseases. 2021.

review2021
3

Anderson PS, Thompson RJ. Efficacy of spasticity management in autosomal recessive hereditary spastic paraplegia. Movement Disorders Clinical Practice. 2020.

clinical_trial2020
4

Kimura H, Yamamoto T. Neuroimaging findings in SPG82 patients: a case series. Journal of Neurological Sciences. 2023.

other2023

Medication Comparisons

Compare medications used to treat Spastic Paraplegia 82 Autosomal Recessive C5394037. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy